BackJazz Pharmaceuticals plc Overview

Jazz Pharmaceuticals plc Receivables

Jazz Pharmaceuticals plc's receivables is $840M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$836.30M
28.07% YoYΔ $183.31M vs prior year quarter

Peer average

Loading

Jazz Pharmaceuticals plc Receivables History

Loading

Jazz Pharmaceuticals plc vs. peers: Receivables Comparison

Loading

Jazz Pharmaceuticals plc Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Jazz Pharmaceuticals plc (JAZZ) FAQ

As of the most recent data (March 2026), JAZZ shows a receivables of $840M. That compares with $650M in the prior-year period — up 28.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JAZZ's receivables is now $840M (was $650M) — a 28.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Jazz Pharmaceuticals plc is outperforming or lagging.

Tracking JAZZ's receivables over time shows whether Jazz Pharmaceuticals plc is scaling, shrinking, or reshaping that part of the business. The current reading is $840M That compares with $650M in the prior-year period — up 28.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Jazz Pharmaceuticals plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $840M) with ownership activity and broader fundamentals.

Jazz Pharmaceuticals plc's receivables is $840M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.